Labo'Life Italia

Labo'Life Italia is the Italian subsidiary of the Labo'Life Group, an international pharmaceutical organization specializing in Micro-Immunotherapy. The company develops and distributes a unique range of medicines designed to regulate the immune system using low doses of immune mediators such as cytokines and specific nucleic acids. Their therapeutic approach, known as the 2L series, utilizes a sequential signaling method to mimic the body's natural physiological responses to pathogens and internal dysregulation. Labo'Life's products target a broad spectrum of conditions, including chronic viral infections, allergies, and autoimmune disorders. The company maintains high quality standards, operating under Good Manufacturing Practice (GMP) to ensure the precision of its micro-dose formulations.